JD Health International
Logotype for JD Health International Inc

JD Health International (6618) investor relations material

JD Health International H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for JD Health International Inc
H1 2026 earnings summary13 Aug, 2026

Executive summary

  • H1 2026 revenue rose 15.9% YoY to RMB40.9bn, driven by growth in product and service revenue.

  • Non-IFRS operating income increased 40.3% to RMB3.5bn; non-IFRS operating margin reached 8.5%, improving for a ninth consecutive quarter.

  • Reported operating income rose 49.2% to RMB3.2bn and profit for the period increased 32.6% to RMB3.4bn.

  • Strategic priorities included user experience, AI-powered healthcare services and supply chain integration.

Financial highlights

  • Product revenue grew 15.6% to RMB33.9bn; service revenue rose 17.2% to RMB7.0bn.

  • Gross profit increased 20.2% to RMB10.7bn; gross margin improved to 26.1% from 25.2%.

  • Fulfillment expenses rose 15.0% to RMB4.1bn, while the ratio to revenue declined to 10.0%.

  • Selling and marketing expenses increased 3.7% to RMB1.9bn, with the ratio to revenue falling to 4.6%; R&D expenses rose 23.5% to RMB909.1m.

  • Basic EPS was RMB1.08, up from RMB0.82 YoY.

Outlook and guidance

  • H2 growth is expected to exceed the industry, with continued strengthening in online pharmacy retail.

  • H2 nutrition and supplements growth is expected to slow from H1, though management anticipates improvement; medical equipment has a positive long-term outlook.

  • The long-term operating margin target remains high single digits, supported by scale, supply chain improvements, AI services and operating efficiency.

  • Scaling healthcare services and balancing high-frequency, lower-margin products with lower-frequency, higher-margin business could support gross margin improvement.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next JD Health International earnings date

Logotype for JD Health International Inc
H2 20264 Mar, 2027
JD Health International
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next JD Health International earnings date

Logotype for JD Health International Inc
H2 20264 Mar, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

JD Health International Inc is a healthcare services company specializing in online medical consultation, pharmaceutical retail, and health management solutions. The company operates a digital platform that connects users with healthcare professionals and provides access to prescription and over-the-counter drugs, medical devices, and wellness products. JD Health also offers chronic disease management, telemedicine, and health-related insurance services, catering to individual and institutional customers. The company is headquartered in Beijing, China, and its shares are listed on the SEHK.